Keywords: glaxo, wellcome, issues, lamictal, warning, issued, risk

Glaxo Wellcome Issues Lamictal Warning

Article | 09 April 1997

Print This

- Glaxo Wellcome has issued a warning that the risk of allergic sideeffects associated with its epilepsy drug Lamictal (lamotrigine), could ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in